Share This Post Cabozantinib improves outcomes for patients without reducing quality of life Read more here: http://news.feinberg.northwestern.edu/2018/02/evaluating-quality-of-life-after-kidney-cancer-treatments/ Share This Post Dena Battle Dena Battle is the President and cofounder of KCCure.